MIRM
MirumCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
MIRM vs peer average
57/100
MIRM vs. peer average (C vs. C)
Grade spread
A 1 · B 3 · C 1 · D 2 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
SRRK is the first available peer comparator.
Rare-disease development-risk reference from the prior baseline, with limited comparability to Mirum's marketed portfolio.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
MIRM
Mirum
SRRK
Scholar Rock
Grade
C
B
Momentum
19
18
Value
41
41
Sentiment
73
82
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs SRRK
MIRM / SRRK
Grade Position
In line
MIRM vs. peer average (C vs. C)
57/100
Momentum
19
MIRMValue
41
MIRMSentiment
73
SRRKRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs MIRM
SRRK is the first peer returned for this comparison set.